170: Targeting hypoxia through autophagy von Rouschop, K

Volltext

SP-0643: Tumor radiosensitization by autophagy-inhibition von Rouschop, K

Volltext

SP-0515 Extracellular vesicles in hypoxia-induced remodelling of the tumour microenvironment von Rouschop, K.

Volltext

Ischemia–reperfusion treatment: opportunities point to modulation of the inflammatory response von Rouschop, K.M.A., Leemans, J.C.

Volltext

The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis von Roelofs, J.J.T.H., Rouschop, K.M.A., Teske, G.J.D., Claessen, N., Weening, J.J., van der Poll, T., Florquin, S.

Volltext

Renal expression of CD44 correlates with acute renal allograft rejection von Rouschop, K.M.A., Roelofs, J.J.T.H., Sylva, M., Rowshani, A.T., ten Berge, I.J.M., Weening, J.J., Florquin, S.

Volltext

SP-0014: Radiation sensitivity and EMT in cancer: Role of the tumor microenvironment von Theys, J, Habets, R, Jutten, B, Groot, A, Paesmans, K, Lambin, P, Rouschop, K, Vooijs, M

Volltext

SP-27: Targeting Autophagy During Radiotherapy von Lammering, G, Jutten, B, Rouschop, K, Buijsen, J, Vooijs, M, Lambin, P

Volltext

PO-1813: Plasma biomarkers of immunogenic cell death during and after SBRT and concurrent chemo-RT for NSCLC von Reynders, K., Garg, A.D., Van Limbergen, E., Agostinis, P., Vansteenkiste, J., Hendriks, L., Rouschop, K., Rucevic, M., Lambrecht, M., De Ruysscher, D.

Volltext

425P - CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma von Compter, I., Eekers, D., Hoeben, A., Rouschop, K., Reymen, B.J., Ackermans, L., Beckervordersantforth, J., Bauer, N., Anten, M., Wesseling, P., Postma, A., De Ruysscher, D., Lambin, P.

Volltext

CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma von Compter, I., Eekers, D., Hoeben, A., Rouschop, K., Reymen, B.J., Ackermans, L., Beckervordersantforth, J., Bauer, N., Anten, M., Wesseling, P., Postma, A., De Ruysscher, D., Lambin, P.

Volltext

425PCHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma von Compter, I, Eekers, D, Hoeben, A, Rouschop, K, Reymen, B J, Ackermans, L, Beckervordersantforth, J, Bauer, N, Anten, M, Wesseling, P, Postma, A, De Ruysscher, D, Lambin, P

Volltext

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney von Leemans, Jaklien C, Stokman, Geurt, Claessen, Nike, Rouschop, Kasper M, Teske, Gwendoline J D, Kirschning, Carsten J, Akira, Shizuo, van der Poll, Tom, Weening, Jan J, Florquin, Sandrine

Volltext

PO-0860: Learning radiation oncology in Europe: results of the ESTRO multidisciplinary survey von Bibault, J., Franco, P., Borst, G., Van Elmpt, W., Thorwhart, D., Schmid, M., Rouschop, K., Spalek, M., Mullaney, L., Røe Redalen, K., Dubois, L., Verfaillie, C., Eriksen, J.

Volltext

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium von Pettersen, Erik O., Ebbesen, Peter, Gieling, Roben G., Williams, Kaye J., Dubois, Ludwig, Lambin, Philippe, Ward, Carol, Meehan, James, Kunkler, Ian H., Langdon, Simon P., Ree, Anne H., Flatmark, Kjersti, Lyng, Heidi, Calzada, Maria J., Peso, Luis del, Landazuri, Manuel O., Görlach, Agnes, Flamm, Hubert, Kieninger, Jochen, Urban, Gerald, Weltin, Andreas, Singleton, Dean C., Haider, Syed, Buffa, Francesca M., Harris, Adrian L., Scozzafava, Andrea, Supuran, Claudiu T., Moser, Isabella, Jobst, Gerhard, Busk, Morten, Toustrup, Kasper, Overgaard, Jens, Alsner, Jan, Pouyssegur, Jacques, Chiche, Johanna, Mazure, Nathalie, Marchiq, Ibtissam, Parks, Scott, Ahmed, Afshan, Ashcroft, Margaret, Pastorekova, Silvia, Cao, Yihai, Rouschop, Kasper M., Wouters, Brad G., Koritzinsky, Marianne, Mujcic, Hilda, Cojocari, Dan

Volltext

Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection von Roelofs, Joris J. T. H., Rouschop, Kasper M. A., Teske, Gwendoline J. D., Wagenaar, Gerry T. M., Claessen, Nike, Weening, Jan J., van der Poll, Tom, Florquin, Sandrine

Volltext

Toll-Like Receptors-Intrarenal Mechanisms beyond Immune Function: Renal-Associated TLR2 Mediates Ischemia/Reperfusion Injury in the Kidney von Leemans, J C, Stokman, G, Claessen, N, Rouschop, K M, Teske, G, Kirschning, C J, Akira, S, van der Poll, T, Weening, J J, Florquin, S

Volltext

Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury. Commentary von ROUSCHOP, K. M. A, LEEMANS, J. C, SANDOVICI, M, HENNING, R. H, VAN GOOR, H, HELFRICH, W, DE ZEEUW, D, DEELMAN, L. E

Volltext

PO-023 Chloroquine sensitises oncogenic NOTCH1 driven human T cell leukaemia to γ-secretase inhibition von Hounjet, J, Habets, R, Schaaf, MB, Hendrickx, TC, Barbeau, LMO, Yahyanejad, S, Rouschop, KM, Groot, AJ, Vooijs, M

Volltext

PO-023 Chloroquine sensitises oncogenic notch1 driven human t cell leukaemia to γ-secretase inhibition von Hounjet, J, Habets, R, Schaaf, MB, Hendrickx, TC, Barbeau, LMO, Yahyanejad, S, Rouschop, KM, Groot, AJ, Vooijs, M

Volltext